R07 Stock Chart & Stats
€0.27
<€0.01(3.01%)
At close: 4:00 PM EDT
€0.27
<€0.01(3.01%)
Day’s Range― - ―
52-Week Range€0.25 - €0.40
Previous CloseN/A
Volume0.00
Average Volume (3M)3.00
Market Cap
€20.38M
Enterprise Value€46.33
Total Cash (Recent Filing)€2.96M
Total Debt (Recent Filing)€15.58M
Price to Earnings (P/E)―
Beta0.24
Next Earnings
Nov 18, 2026EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding67,578,920
10 Day Avg. Volume11
30 Day Avg. Volume3
Financial Highlights & Ratios
PEG Ratio-0.22
Price to Book (P/B)0.71
Price to Sales (P/S)0.53
P/FCF Ratio-2.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€0.72Price Target Upside164.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)€45.38M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthRubicon’s record quarterly revenue and strong year-over-year growth indicate improving product availability, brand demand, and distribution execution. Continued top-line expansion can support better fixed-cost absorption and provide a foundation for margin recovery as the company scales.
Premium Brand And Market Share StrengthLeadership in premium flower and meaningful contribution from recognized brands demonstrate competitive positioning in a regulated market. Stronger share and consumer recognition can support repeat purchases, protect product mix, and improve the durability of future revenue growth.
Cultivation And Capacity ImprovementHigher Pacifica yields and a pathway to greater production capacity improve Rubicon’s ability to supply premium products while spreading operating costs over more volume. If sustained, these initiatives can strengthen throughput, support growth, and create operating leverage.
Bears Say
Severe Gross Margin CompressionThe sharp decline in gross margin shows that revenue growth is not currently translating into healthy profitability. Persistent cost, pricing, or product-mix pressure could weaken earnings quality, limit reinvestment capacity, and delay the achievement of sustainable operating returns.
Negative Operating And Free Cash FlowNegative operating and free cash flow indicate that Rubicon is not yet consistently funding its operations and investment internally. Continued cash burn can increase dependence on external financing, constrain strategic flexibility, and make execution more sensitive to delays in the growth plan.
Liquidity And Scaling Execution RiskLimited cash provides less room to absorb delays while Cascadia ramps toward planned production and targeted margins. Below-target yields could postpone the facility’s contribution, increase the need for careful spending, and extend the period before recent investments generate full financial benefits.
Rubicon Organics News
R07 FAQ
What was Rubicon Organics Inc’s price range in the past 12 months?
Rubicon Organics Inc lowest stock price was €0.25 and its highest was €0.40 in the past 12 months.
What is Rubicon Organics Inc’s market cap?
Rubicon Organics Inc’s market cap is €20.38M.
When is Rubicon Organics Inc’s upcoming earnings report date?
Rubicon Organics Inc’s upcoming earnings report date is Nov 18, 2026 which is in 66 days.
How were Rubicon Organics Inc’s earnings last quarter?
Rubicon Organics Inc released its earnings results on Aug 11, 2026. The company reported €0.006 earnings per share for the quarter, beating the consensus estimate of -€0.003 by €0.009.
Is Rubicon Organics Inc overvalued?
According to Wall Street analysts Rubicon Organics Inc’s price is currently Undervalued.
Does Rubicon Organics Inc pay dividends?
Rubicon Organics Inc does not currently pay dividends.
What is Rubicon Organics Inc’s EPS estimate?
Rubicon Organics Inc’s EPS estimate is <0.01.
How many shares outstanding does Rubicon Organics Inc have?
Rubicon Organics Inc has 67,578,920 shares outstanding.
What happened to Rubicon Organics Inc’s price movement after its last earnings report?
Rubicon Organics Inc reported an EPS of €0.006 in its last earnings report, beating expectations of -€0.003. Following the earnings report the stock price went down -10.909%.
Which hedge fund is a major shareholder of Rubicon Organics Inc?
Currently, no hedge funds are holding shares in DE:R07
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rubicon Organics Inc
Rubicon Organics Inc. cultivates, processes, and distributes organic cannabis products for both recreational and medicinal consumers across Canada. The company markets its organic cannabis through its proprietary labels as well as various licensed brands. Founded in 2015, Rubicon Organics Inc. maintains its headquarters in Vancouver, Canada.
R07 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated clear operational momentum (record revenue, 20% yield gains at Pacifica, Cascadia brought online and certified, market share gains, and margin improvement potential excluding Cascadia start-up costs) alongside typical early-stage scaling challenges (Cascadia yields below targets, modest Q2 Cascadia revenue, higher SG&A, slight YoY decline in adjusted EBITDA, and limited cash). Management offered a coherent plan (yield optimization, in-house extraction, automation, portfolio optimization, international expansion) and expects margin and EBITDA ramp in H2 2026 into 2027. Overall, positives (revenue growth, operational wins, brand strength, certifications) materially outweigh the near-term costs and execution risks.View all DE:R07 earnings summariesR07 Stock 12 Month Forecast
Average Price Target
€0.72
▲(164.85% Upside)